Among these biomarkers, natriuretic peptides, including B-type natriuretic peptide (BNP) and the N-terminal fragment of its prohormone (NT-proBNP), have emerged as approved biomarkers for HF [9]. This evidence concerns the gene NPPB and hydrops fetalis.